Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK, Efficacy and Safety of Nuwiq in Severe Hemophilia A
NCT00989196Phase 2Completed
- Sponsor
- Octapharma
- Start
- May 2010
- Primary completion
- Oct 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 3
01
Overview
A Phase 2 trial of simoctocog alfa in hemophilia A, sponsored by Octapharma. Started May 2010; status: completed.
02
Drugs
simoctocog alfa
03
Conditions
hemophilia A
Beyond the preview
Go deeper on NCT00989196.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00989196.